Gestione del paziente affetto da diabete mellito T2: la presa in carico ottimizzata
Celeste Berra C. C., Pradelli L. – Farmeconomia. Health economics and therapeutic pathways 2021; 22(S2): 1-16
The contribution of patients’ lung function to the inspiratory airflow rate achievable through a DPIs’ simulator reproducing different intrinsic resistance rates
Dal Negro R W, Turco P, Povero M. – Multidis Res Med 2021 Apr.15;16
Assessing the global usability of dry powder inhalers: analysis of six devices widely used for asthma
Dal Negro R W, Turco P, Povero M. – J Pulm Med Respir Res 2021
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
Carpagnano GE, Resta E, Povero M, Pelaia C, D’Amato M, Crimi N, Scichilone N, Scioscia G, Resta O, Calabrese C, Pelaia G, Barbaro – Sci Rep. 2021 Mar
Preliminary cost-effectiveness and cost-utility analysis of cemiplimab in patients with advanced cutaneous squamous cell carcinoma in Italy
Ghetti G, D’Avella MC, Pradelli L. – Clinicoecon Outcomes Res. 2021;13:121-133. Published 2021 Feb 10
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
Bagnasco D, Povero M, Pradelli L, Brussino L, Rolla G, Caminati M, Menzella F, Heffler E, Canonica GW, Paggiaro P, Senna G, Milanese M, Lombardi C, Bucca C, Manfredi A, Canevari RF, Passalacqua G; SANI Network (Severe Asthma Network Italy). – World Allergy Organ J. 2021 Jan 27;14(2):100509
Clinical and Economic Rationale for the Early use of SGLT2 Inhibitors in Patients with Type 2 Diabetes
Mannucci E., Mangia P. P. , Pradelli L. – Farmeconomia. Health economics and therapeutic pathways 2020; 21(S1): 3-20
Assessing the effect of nutrition therapy on rehospitalization rate in malnourished pediatric patients with chronic diseases
Lezo A, Povero M, Pradelli L, Nigro E, Plazzotta C, Lagazio C. – {published online ahead of print, 2020 Nov 14}. JPEN J Parenter Enteral Nutr. 2020;10.1002/jpen.2046
Summary of proceedings and expert consensus statements from the international summit “lipids in parenteral nutrition
Martindale, RG, Berlana, D, Boullata, JI, Cai, W, Calder, PC, Deshpande, GH, Evans, D, Garcia-de-Lorenzo, A, Goulet, OJ, Li, A, Mayer, K, Mundi, MS, Muscaritoli, M, Pradelli, L, Rosenthal, M, Seo, JM, Waitzberg, DL & Klek, S 2020,. – Journal of Parenteral and Enteral Nutrition, vol. 44, no. S1, pp. S7-S20
Pharmacoeconomics of parenteral nutrition with ω-3 fatty acids in hospitalized adults
Pradelli L, Muscaritoli M, Klek S, Martindale RG. – JPEN J Parenter Enteral Nutr. 2020;44 Suppl 1:S68-S73
Ω-3 fatty-acid enriched parenteral nutrition in hospitalized patients: systematic review with meta-analysis and trial sequential analysis
Pradelli L, Mayer K, Klek S, et al. – JPEN J Parenter Enteral Nutr. 2020;44(1):44-57
The global usability score short-form for the simplified assessment of dry powder inhalers (DPIs) usability
Povero M, Turco P, Bonadiman L, Dal Negro RW. – Multidiscip Respir Med. 2020;15(1):659. Published 2020 Jul 21
A computational framework for modeling and studying pertussis epidemiology and vaccination
Castagno P, Pernice S, Ghetti G, et al. – BMC Bioinformatics. 2020;21(Suppl 8):344. Published 2020 Sep 16
Funding innovation thanks to anti-tnf-α biosimilars uptake: the economic impact in Italy
Povero M, Pradelli P. – Farmeconomia. Health economics and therapeutic pathways 2020; 21(1): 37-47
Patients’ usability of seven most used dry-powder inhalers in COPD
Dal Negro RW, Turco P, Povero M. – Multidisciplinary respiratory medicine (2019). 14(1)
Acute cough in italian children: parents’ beliefs, approach to treatment, and the family impact
Dal Negro RW, Zanasi A, Turco P, Povero M. – Multidisciplinary respiratory medicine (2019). 14(1)
Effectiveness of long-acting injectable antipsychotics in schizophrenia: a literature review and bayesian meta-analysis informing economic considerations
Zaniolo O, Ghetti G, Povero M, Pradelli L. – Farmeconomia. Health economics and therapeutic pathways 2019; 20(1): 13-24
Cost-utility of surgical sutureless bioprostheses vs tavi in aortic valve replacement for patients at intermediate and high surgical risk
Povero M, Miceli A, Pradelli L, Ferrarini M, Pinciroli M, Glauber M. – Clinicoecon Outcomes Res 2018 Nov 8;10:733-745
Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in latin america
Correia MITD, Perman MI, Pradelli L, Omaralsaleh AJ, Waitzberg DL. – J Med Econ 2018 Nov;21(11):1047-1056
Propofol vs. Inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis
Schraag S, Pradelli L, Alsaleh AJO, Bellone M, Ghetti G, Chung TL, Westphal M, Rehberg S. – BMC Anesthesiol 2018 Nov 8;18(1):162
Cost of influenza and influenza-like syndromes (I-LSs) in Italy: results of a cross-sectional telephone survey on a representative sample of general population
Dal Negro RW, Turco P, Povero M. – Respiratory Medicine, Volume 141, 144-149
Influenza and influenza-like syndromes: the subjects’ beliefs, the attitude to prevention and treatment, and the impact in italian general population
Dal Negro RW, Zanasi A, Turco P, Povero M. – Multidisciplinary Respiratory Medicine (2018) 13:7
Cost of acute cough in italian children
Dal Negro RW, Turco P, Povero M. – ClinicoEconomics and Outcomes Research 2018:10 529–537
Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation
Bellone M, Pradelli L, Bo M. – Farmeconomia. Health economics and therapeutic pathways 2018; 19(1): 11-20
Albutrepenonacog alfa (idelvion®) for the treatment of italian patients with hemophilia b: a budget impact model
Pradelli L, Villa S, Castaman G. – Farmeconomia. Health economics and therapeutic pathways 2018; 19(1): 1-10
Propofol or benzodiazepines for short- and long-term sedation in intensive care units? An economic evaluation based on meta-analytic results
Pradelli L, Povero M, Bürkle H, Kampmeier TG, Della-Rocca G, Feuersenger A, Baron JF, Westphal M. – Clinicoecon Outcomes Res. 2017 Nov 9;9:685-698
Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysis
Feng Y, Li C, Zhang T, Pradelli L. – Clinicoecon Outcomes Res. 2017 Sep 5;9:547-555
Lipids in the intensive care unit: recommendations from the ESPEN expert group
Calder PC, Adolph M, Deutz NE, Grau T, Innes JK, Klek S, Lev S, Mayer K, Michael-Titus AT, Pradelli L, Puder M, Vlaardingerbroek H, Singer P. – Clin Nutr. 2017 Sep 7. pii: S0261-5614(17)30315-1
Overall effectiveness of pneumococcal conjugate vaccines: an economic analysis of PHID-CV and PCV-13 in the immunization of infants in Italy
Castiglia P, Pradelli L, Castagna S, Freguglia V, Palù G, Esposito S. – Hum Vaccin Immunother. 2017 Oct 3; 13(10): 2307-2315
A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the italian context
Pradelli L, Di Perri G, Rizzardini G, Martelli E, Giardina S, Povero M. – Farmeconomia. Health economics and therapeutic pathways 2017; 18(1): 113-127
A general model for the estimation of societal costs of lost production and informal care in Italy
Pradelli L, Ghetti G. – Farmeconomia. Health economics and therapeutic pathways 2017; 18(1): 5-14
The global usability score: a novel comprehensive tool for assessing, ranking, and compare usability of inhalers in patients requiring airway treatments
Dal Negro R, Turco P, Povero M. – Pulm Respir Med. 2017;7:401
Pharmacoeconomics of parenteral nutrition in surgical and critically ill patients receiving structured triglycerides in China
Wu GH, Ehm A, Bellone M, Pradelli L. – Asia Pac J Clin Nutr. 2017; 26(6): 1021-1031
Supplemental parenteral nutrition in intensive care patients: a cost saving strategy
Pradelli L, Graf S, Pichard C, Berger MM. – Clin Nutr. 2017 Jan 25. pii: S0261-5614(17)30033-X
Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy
Bellone M, Di Virgilio R, Di Rienzo P. – Farmeconomia. Health economics and therapeutic pathways 2016; 17(3): 127-136
The contribution of patients’ lung function to the inspiratory airflow rate achievable through a DPIs’ simulator reproducing different intrinsic resistance rates
Dal Negro R W, Turco P, Povero M. – Multidis Res Med 2021 Apr.
Valutazione clinica ed economica dell’introduzione sul mercato italiano della combinazione trametinib + dabrafenib nel trattamento del melanoma in stadio avanzato
Pradelli L, Ascierto P. – Farmeconomia. Health economics and therapeutic pathways 2016; 17(Suppl 3): 1-32
Cultural and linguistic validation of the NHQ-2 questionnaire: a specific instrument for assessing patient’s usability of inhalation devices
Dal Negro W, Povero M – Multidiscip Respir Med. 2016 Aug 23;11:32
Dry-powder inhalers in patients with persistent airflow limitation: usability and preference
Dal Negro W, Povero M. – Multidiscip Respir Med. 2016 Sep 5;11:31
Acceptability and preference of three inhalation devices assessed by the handling questionnaire in asthma and copd patients
Dal Negro W, Povero M. – Multidiscip Respir Med. 2016 Feb 10;11:7
Simulating the development and progression of Chronic Kidney Disease and osteoporosis in people living with HIV
Adami S, Maggi P, Montinaro V, Povero M, Pradelli L, Bellagamba R, Bonfanti P, Di Biagio A, Rusconi S, Di Campli FM, Forastieri G, Mancini M. – Farmeconomia. Health economics and therapeutic pathways 2016;17(S1):3-23
Structured triglycerides versus physical mixtures of medium- and long-chain triglycerides for parenteral nutrition in surgical or critically ill adult patients: systematic review and meta-analysis
Wu GH, Zaniolo O, Schuster H, Schlotzer E, Pradelli L. – Clinical Nutrition, epub available online 21 January 2016
Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. Adaptation of a differential cost analysis
Povero M, Pradelli L. – Farmeconomia. Health economics and therapeutic pathways 2015;16(S1):3-16.
Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in US
Povero M, Pradelli L. – Farmeconomia. Health economics and therapeutic pathways 2015;16(3):77-86.
Cost and effectiveness of omega-3 fatty acid supplementation in chinese icu patients receiving parenteral nutrition
Wu GH, Gao J, Ji CY, Pradelli L, Xi QL, Zhuang QL. – MClinicoecon Outcomes Res. 2015 Jun 26;7:369-75.
Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients
Pradelli L, Povero M, Muscaritoli M, Eandi M. – Eur J Clin Nutr 2015 May;69(5):546-51
Plasma for fractionation in a public setting: cost analysis from the perspective of the third-party payer
Eandi M, Gandini G, Povero M, Zaniolo O, Pradelli L, Aprili G. – Blood Transfus 2015 Jan;13(1):37-45
Comparative pharmaco-economic assessment of apixaban versus standard of care for the prevention of stroke in italian atrial fibrillation patients
Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. – Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 15-25
Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in italian atrial fibrillation patients
Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. – Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 5-14
Cost effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in italian atrial fibrillation patients
Pradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. – Farmeconomia. Health economics and therapeutic pathways 2014; 15(4): 101-112
